Alcohol use disorder is a medical disease, not a moral failing — and effective treatment exists. Icon Medicine offers FDA-approved MAT for AUD with naltrexone, Vivitrol, acamprosate, and disulfiram — same-day telehealth starts, no judgment, board-certified care.
Alcohol Use Disorder (AUD) is a chronic medical condition diagnosed when a patient's drinking pattern leads to significant impairment or distress. According to the National Institute on Alcohol Abuse and Alcoholism (NIAAA), AUD exists on a spectrum — mild, moderate, or severe — based on how many DSM-5 criteria are met over a 12-month period.
Despite being legal and socially common, alcohol is among the most dangerous substances a person can regularly consume. Chronic heavy drinking reshapes the brain's reward, stress, and sleep systems, creating tolerance and a physical withdrawal syndrome that can be life-threatening when unmanaged. The good news: AUD responds well to evidence-based medication-assisted treatment (MAT).
Common patterns: daily drinking, nightly heavy use, weekend binges, "controlled" daily drinking that escalates, drinking in the morning to relieve hangovers, and difficulty stopping after the first drink. Any pattern that reflects loss of control, tolerance, or withdrawal qualifies for clinical evaluation.
AUD is a clinically recognized substance use disorder recognized by the American Psychiatric Association and NIAAA. It follows the same DSM-5 diagnostic framework as other substance use disorders — and it is treatable with FDA-approved medications.
Severity Tiers: AUD is diagnosed when 2 or more DSM-5 criteria are met within a 12-month period. Mild AUD = 2–3 criteria, Moderate = 4–5 criteria, Severe = 6+ criteria. Severity guides medication choice and level of care — Icon Medicine tailors MAT to where you fall on this spectrum.
Prevalence: Approximately 28 million US adults (≈11% of the adult population) meet criteria for past-year AUD, according to NIAAA's most recent national survey. Fewer than 1 in 10 receives any FDA-approved medication — leaving a massive treatment gap that telehealth MAT is uniquely positioned to close.
AUD presents across physical, behavioral, and psychological dimensions. Recognizing these signs is the first step toward recovery.
Alcohol withdrawal can be life-threatening — unlike most other substance withdrawals. Understanding the timeline underscores why supervised medical management is essential, not optional.
Tremors (often starting in the hands), anxiety, agitation, headache, nausea, sweating, insomnia, and a racing heart emerge as blood alcohol drops. Many patients mistake early symptoms for a bad hangover — but they are the first signals of a withdrawal curve that can escalate quickly.
Tremor worsens and becomes visible. Profuse sweating, palpitations, elevated blood pressure, vomiting, stomach pain, and pronounced anxiety intensify. Cravings become overwhelming. This is the window where Icon Medicine reaches out to initiate outpatient monitoring and medication if not already in treatment.
The most medically dangerous window for tonic-clonic (grand mal) seizures. Heavy, long-term drinkers and those who've previously withdrawn are at highest risk. Visual or auditory hallucinations can also appear. Inpatient or intensive outpatient monitoring, plus anti-seizure medication, is standard of care at this stage.
Delirium tremens is a true medical emergency: severe confusion, autonomic instability (dangerous heart-rate and blood-pressure swings), high fever, profound disorientation, and vivid hallucinations. DTs are fatal in up to 15% of untreated cases — but with prompt medical care, mortality drops below 1%. Anyone progressing to this stage requires hospitalization.
For patients who progress safely through the peak window, acute withdrawal begins to wind down. Tremor, sweating, and GI distress subside. Sleep remains fragmented, appetite returns, and mood starts to lift. Anti-craving medication (naltrexone, acamprosate) can typically be initiated or optimized now.
Intermittent cravings, mood swings, sleep disturbance, anxiety, and low motivation can persist for weeks to months after acute withdrawal resolves. PAWS is the highest-risk window for relapse. Ongoing MAT, behavioral support, and structured follow-up are how Icon Medicine protects long-term recovery during this phase.
Our six-step protocol is built around the four FDA-approved medications for AUD — naltrexone, Vivitrol, acamprosate, and disulfiram — personalized, compassionate, and delivered entirely via telehealth with medical monitoring for withdrawal safety.
Your first appointment is a confidential telehealth visit. Our provider conducts a comprehensive AUD assessment — how much and how often you drink, history of withdrawal or seizures, prior quit attempts, and co-occurring conditions such as anxiety, depression, PTSD, or chronic pain. This usually takes 45–60 minutes and can happen the same day you reach out.
Based on your assessment, we choose the right FDA-approved medication for your goals. Patients aiming for reduced drinking often do well on oral naltrexone; those aiming for abstinence with adherence support benefit from Vivitrol (monthly injection); acamprosate is preferred for post-withdrawal craving control; disulfiram is reserved for motivated patients who want a deterrent. Your drinking history, medical history, and personal goals drive the choice.
Naltrexone blocks opioid receptors involved in alcohol's reward and craving pathways — published evidence (including the landmark COMBINE Study) shows it reduces heavy drinking days by roughly 25%. Vivitrol is the same medication as a once-monthly intramuscular injection, eliminating daily dosing and improving adherence for patients who want built-in accountability. Naltrexone can only be started once you are opioid-free for 7–10 days and typically after withdrawal symptoms have settled, so the timing is coordinated with your provider.
Because alcohol withdrawal can be life-threatening, we actively monitor you during the highest-risk window (hours 6–72). For most patients, telehealth-based monitoring with scheduled check-ins, vital-sign review, and as-needed medications is appropriate. Patients with severe AUD, prior seizures, or signs of delirium tremens are referred for inpatient detox and step back into our MAT program when medically cleared. All follow-up visits occur via telehealth — no travel, no waiting rooms, full privacy.
Once stable, we work with you on a maintenance plan that fits your goals. Many patients stay on naltrexone or Vivitrol for 6–12 months or longer to protect against relapse during the highest-risk window for cravings. Others taper off medication after sustained remission. Both paths are medically valid and evidence-based. We never force a timeline on your recovery.
MAT works best alongside behavioral support. We connect you with counseling resources, peer-support groups, and provide ongoing monitoring for co-occurring conditions — anxiety, depression, PTSD, and chronic pain — that often drive drinking in the first place. Treating the whole person is the foundation of lasting recovery.
Alcohol withdrawal can be fatal — unlike most other substance withdrawals. Here is why medically supervised care is essential, not optional.
Unsupervised alcohol detox carries a real risk of seizures and delirium tremens (DTs) — a medical emergency with mortality up to 15% when untreated. Seizures typically hit between hours 24–48; DTs between hours 48–72. Medical evaluation, seizure precautions, and appropriate medication dramatically lower risk. Don't quit cold turkey alone — even if you've "done it before."
Most people with AUD use alcohol to self-medicate something: anxiety, depression, PTSD, chronic pain, insomnia, or trauma. Treatment that ignores these drivers leaves patients vulnerable to relapse or substitution with another substance. We screen and treat the whole picture — including mental-health support via our integrated psychiatric team.
Heavy, prolonged alcohol use damages the liver, heart, brain, and nervous system — fatty liver disease, alcoholic hepatitis, cardiomyopathy, peripheral neuropathy, and alcohol-attributable cancers are common. A medical provider can order baseline labs, monitor organ function, and manage complications while you're in treatment — protecting your overall health throughout recovery.
Our treatment protocols are grounded in published peer-reviewed evidence. If you need immediate support, free and confidential help is available 24/7.
National Institute on Alcohol Abuse and Alcoholism overview of AUD treatment options, including medication, behavioral therapies, and mutual-support groups.
niaaa.nih.gov — Treatment for Alcohol ProblemsFree, confidential, 24/7 treatment referral and information service for individuals facing substance use disorders.
1-800-662-4357FDA approval announcement for extended-release naltrexone (Vivitrol) for the treatment of alcohol dependence — landmark move expanding MAT access beyond opioid use disorder.
FDA Prescribing Information (PDF)"Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (The COMBINE Study)." JAMA, 295(17):2003–2017. Landmark RCT showing naltrexone significantly reduces heavy drinking days when combined with medical management.
Pharmacological extinction approach using naltrexone taken only before drinking. Documented in peer-reviewed literature and used internationally for harm-reduction AUD treatment.
Treatment Improvement Protocol covering the four FDA-approved AUD medications, including clinical workflow, dosing, and patient-selection guidance for primary care and addiction medicine providers.
MAT for substance use disorders is covered under most insurance plans. Transparent self-pay pricing is always available with no hidden fees.
We accept most major commercial insurance plans. Coverage for MAT is required under the Mental Health Parity and Addiction Equity Act (MHPAEA). Call us to verify your specific benefits before your appointment.
Don't see your plan listed? Call (240) 966-4266 — we verify coverage for all major insurers.
You've been managing this alone long enough. Icon Medicine offers same-day, judgment-free AUD treatment via telehealth — from the privacy of your home, starting today.
This page is for informational purposes only and does not constitute medical advice. Alcohol Use Disorder treatment should be supervised by a qualified healthcare provider. If you are experiencing a medical emergency — including active withdrawal, seizures, or thoughts of harming yourself — call 911 or go to your nearest emergency room. Icon Medicine is a telehealth practice licensed in Maryland, Virginia, and Florida.